Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether statin could prevent recurrence of
hepatocellular carcinoma after curative treatment
Phase:
Phase 4
Details
Lead Sponsor:
Chiayi Christian Hospital
Collaborators:
Chi Mei Medical Hospital E-DA Hospital Mackay Memorial Hospital National Cheng-Kung University Hospital National Taiwan University Hospital Taichung Veterans General Hospital Tainan Municipal Hospital